• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Catheter ablation for atrial fibrillation (AF) has emerged as an important rhythm-control
strategy and is by far the most common cardiac ablation procedure performed worldwide …

Obesity is already a major global public health issue, implicated in a vast array of conditions
affecting multiple body systems. It is now also firmly established as an independent risk …

The prevalence of atrial fibrillation (AF) and obesity are rising significantly. There is a shared
association between these conditions with obesity predisposing individuals to a number of …

Historically, atrial fibrillation has been observed in clinical settings of prolonged
hemodynamic stress, eg, hypertension and valvular heart disease. However, recently, the …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in
cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity …

Obesity and diabetes can lead to heart failure with preserved ejection fraction (HFpEF),
potentially because they both cause expansion and inflammation of epicardial adipose …